MXPA06013168A - Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. - Google Patents

Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.

Info

Publication number
MXPA06013168A
MXPA06013168A MXPA06013168A MXPA06013168A MXPA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A MX PA06013168 A MXPA06013168 A MX PA06013168A
Authority
MX
Mexico
Prior art keywords
transdermal delivery
parathyroid hormone
hormone agents
microprojection member
epidermis
Prior art date
Application number
MXPA06013168A
Other languages
English (en)
Inventor
Yuh-Fun Maa
Peter Daddona
Mahmoud Ameri
Michael J N Cormier
Marika Kamberi
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA06013168A publication Critical patent/MXPA06013168A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Abstract

Un aparato y metodo para suministrar transdermicamente un agente biologicamente activo que comprende un sistema de suministro que tiene un elemento de microproyeccion 30 (o sistema) que incluye una pluralidad de microproyecciones 32 (o disposicion de las mismas) que se adaptan para perforar a traves del estrato corneo en la capa de epidermis subyacente o las capas de la epidermis y de la dermis; en una modalidad, el agente a base de PTH esta contenido en un revestimiento biocompatible 35 que se aplica al elemento de microproyeccion.
MXPA06013168A 2004-05-13 2005-03-18 Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. MXPA06013168A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57130404P 2004-05-13 2004-05-13
US58527604P 2004-07-01 2004-07-01
US64366005P 2005-01-12 2005-01-12
PCT/US2005/009147 WO2005112984A2 (en) 2004-05-13 2005-03-18 Apparatus and method for transdermal delivery of parathyroid hormone agents

Publications (1)

Publication Number Publication Date
MXPA06013168A true MXPA06013168A (es) 2007-05-15

Family

ID=35428853

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06013168A MXPA06013168A (es) 2004-05-13 2005-03-18 Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.

Country Status (12)

Country Link
US (4) US7556821B2 (es)
EP (1) EP1744683B1 (es)
JP (2) JP5007427B2 (es)
AR (1) AR048887A1 (es)
AU (1) AU2005244734A1 (es)
BR (1) BRPI0509788A (es)
CA (1) CA2566032A1 (es)
ES (1) ES2568259T3 (es)
IL (1) IL179197A0 (es)
MX (1) MXPA06013168A (es)
NO (1) NO20065720L (es)
WO (1) WO2005112984A2 (es)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69719761T2 (de) * 1996-06-18 2003-12-18 Alza Corp Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
US7419481B2 (en) * 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
MXPA03003299A (es) * 2000-10-13 2004-12-13 Johnson & Johnson Aparato y metodo para perforacion de la piel con microsalientes.
NZ525551A (en) * 2000-10-26 2005-09-30 Alza Corp Transdermal drug delivery devices having coated microprotrusions
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
CN100464800C (zh) * 2002-06-28 2009-03-04 阿尔扎公司 具有被涂覆的微突物的经皮药物传输装置
EP1680154B1 (en) 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
AU2005235990A1 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of multiple vaccines
EP1744683B1 (en) * 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
CA2579509A1 (en) * 2004-09-08 2006-03-16 Alza Corporation Microprojection array with improved skin adhesion and compliance
EP1924364A1 (en) * 2005-09-12 2008-05-28 Alza Corporation Coatable transdermal delivery microprojection assembly
AU2006315132A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CA2629193C (en) * 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
JP2009522288A (ja) * 2005-12-28 2009-06-11 アルザ コーポレイション 安定な治療剤形
US9610459B2 (en) 2009-07-24 2017-04-04 Emkinetics, Inc. Cooling systems and methods for conductive coils
US9339641B2 (en) 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
WO2007106597A2 (en) * 2006-03-15 2007-09-20 Alza Corporation Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
WO2007127811A2 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with grouped microprojections for high drug loading
WO2007127815A2 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with multilayered microprojection member for high drug loading
US10786669B2 (en) 2006-10-02 2020-09-29 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US11224742B2 (en) 2006-10-02 2022-01-18 Emkinetics, Inc. Methods and devices for performing electrical stimulation to treat various conditions
US9005102B2 (en) 2006-10-02 2015-04-14 Emkinetics, Inc. Method and apparatus for electrical stimulation therapy
WO2008042902A2 (en) 2006-10-02 2008-04-10 Emkinetics, Inc. Method and apparatus for magnetic induction therapy
AU2008241470B2 (en) 2007-04-16 2013-11-07 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
AU2009255619A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
EP2383013A4 (en) * 2008-12-26 2012-11-28 Hisamitsu Pharmaceutical Co MICRO NEEDLE DEVICE
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery
US20100286600A1 (en) * 2009-05-08 2010-11-11 Bommannan D Bommi Transdermal patch device
AU2010313487A1 (en) 2009-10-26 2012-05-24 Emkinetics, Inc. Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CA2790923C (en) 2010-02-24 2017-10-31 Toshiyuki Matsudo Micro-needle device and preparation method
AU2011248108B2 (en) * 2010-05-04 2016-05-26 Corium Pharma Solutions, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
SI2568806T1 (sl) 2010-05-12 2016-09-30 Radius Health, Inc. Režimi zdravljenja
US8588884B2 (en) 2010-05-28 2013-11-19 Emkinetics, Inc. Microneedle electrode
JP5965909B2 (ja) 2010-09-28 2016-08-10 ラジウス ヘルス，インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
WO2012075375A1 (en) * 2010-12-02 2012-06-07 Lanco Biosciences, Inc. Delivery of parathyroid hormones by microinjection systems
CN103391798A (zh) 2011-02-24 2013-11-13 久光制药株式会社 微针装置用glp-1类似物组合物
JP5695731B2 (ja) * 2011-02-24 2015-04-08 久光製薬株式会社 マイクロニードルデバイス用生理活性非水組成物及びマイクロニードル上に付着している生理活性非水組成物
BR112013027153A2 (pt) 2011-04-22 2016-11-29 3M Innovative Properties Co método de aplicação de fármaco para pth, pthrp e peptídeos relacionados
CN103561757B (zh) * 2011-06-07 2016-01-06 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法
US10980865B2 (en) 2012-08-10 2021-04-20 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
US9173598B1 (en) * 2012-08-27 2015-11-03 Abdullah Khalid Al Rasheed Device for piercing the skin to obtain a blood sample and method of use
MX2015002205A (es) 2012-08-30 2015-05-08 Teijin Ltd Arreglo de microagujas recubiertas con composicion de farmaco.
US11052231B2 (en) 2012-12-21 2021-07-06 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
MY173041A (en) 2013-02-13 2019-12-20 Hisamitsu Pharmaceutical Co Microneedle coating composition and microneedle device
EP2957297B1 (en) 2013-02-13 2018-08-22 Hisamitsu Pharmaceutical Co., Inc. Microneedle-coating composition and microneedle device
JP6081215B2 (ja) * 2013-02-13 2017-02-15 久光製薬株式会社 コーティング及びマイクロニードルデバイス
KR102332671B1 (ko) 2013-03-12 2021-11-30 코리움, 인크. 미세돌기 어플리케이터
EP2968116A1 (en) 2013-03-15 2016-01-20 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
CA2903459C (en) 2013-03-15 2024-02-20 Corium International, Inc. Multiple impact microprojection applicators and methods of use
CA2906541C (en) 2013-03-15 2022-06-21 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
US20150038897A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-Profile Microneedle Patch Applicator
JP5728552B2 (ja) 2013-10-18 2015-06-03 ユニ・チャーム株式会社 不織布の嵩回復装置、及び不織布の嵩回復方法
JP5728553B2 (ja) 2013-10-18 2015-06-03 ユニ・チャーム株式会社 不織布の嵩回復装置、及び不織布の嵩回復方法
WO2016036866A1 (en) 2014-09-04 2016-03-10 Corium International, Inc. Microstructure array, methods of making, and methods of use
WO2016081616A2 (en) * 2014-11-18 2016-05-26 4P Therapeutics Transdermal patch formulations for delivery of water soluble drugs, peptides, proteins and oligosaccharides
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
MX2021005561A (es) 2015-04-29 2022-07-01 Radius Pharmaceuticals Inc Rad1901 para usarse en el tratamiento de cancer en sujetos con cancer positivo a receptor de estrogeno alfa resistente a farmaco.
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
JP7116680B2 (ja) * 2015-10-09 2022-08-10 キンデーバ ドラッグ デリバリー リミティド パートナーシップ コーティングされたマイクロニードルアレイのための亜鉛組成物
WO2017137402A1 (en) * 2016-02-08 2017-08-17 Lunaphore Technologies Sa Methods of sample cycle multiplexing and in situ imaging
WO2017143345A1 (en) 2016-02-19 2017-08-24 Zp Opco, Inc. Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
CA3020333A1 (en) * 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
AU2017281038B2 (en) 2016-06-22 2021-09-09 Ellipses Pharma Ltd AR+ breast cancer treatment methods
CN110191707A (zh) 2017-01-05 2019-08-30 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
KR102340393B1 (ko) 2017-08-23 2021-12-17 조사노 파마 코포레이션 편두통 및 군발성 두통의 치료를 위한 졸미트립탄의 치료적 농도를 신속하게 달성하는 방법
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
EP3685849A4 (en) * 2017-09-22 2021-12-22 Asahi Kasei Pharma Corporation LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TRIPARATIDE WITH EXCELLENT STABILITY
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123212A (en) 1964-03-03 Multiple disposable intracutaneous injector package
USRE25637E (en) 1964-09-08 Means for vaccinating
US2619962A (en) 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
US2893392A (en) 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections
US3072122A (en) 1959-01-15 1963-01-08 Rosenthal Sol Roy Package for transcutaneous injection
US3221739A (en) 1962-03-26 1965-12-07 Rosenthal Sol Roy Injection device
US3221740A (en) 1962-08-31 1965-12-07 Rosenthal Sol Roy Injection device
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3678150A (en) 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
BE795384A (fr) * 1972-02-14 1973-08-13 Ici Ltd Pansements
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
SE8501990D0 (sv) 1985-04-24 1985-04-24 Pharmacia Ab Beleggningsforfarande
US5420242A (en) 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
DE3722775A1 (de) 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US5169382A (en) 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5208041A (en) * 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
ES2129048T3 (es) * 1991-12-09 1999-06-01 Asahi Chemical Ind Composicion estabilizada de hormona paratiroide.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
US5225098A (en) * 1992-03-20 1993-07-06 The Procter & Gamble Company Neutral pH freezer bar and process
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
IT1255723B (it) 1992-10-09 1995-11-13 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
WO1994016710A1 (en) * 1993-01-21 1994-08-04 Janssen Pharmaceutica N.V. Topical ketoconazole compositions
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
TW303299B (es) * 1993-07-22 1997-04-21 Lilly Co Eli
US5679647A (en) * 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
DE4341444C2 (de) 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CA2204777A1 (en) * 1994-11-15 1996-05-23 Steven Scott Porter Skin care compositions and methods
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
DE59509430D1 (de) 1995-01-14 2001-08-23 Heinrich Bauer Wärmeträgerkonzentrat, verfahren zu dessen herstellung sowie dessen verwendung und latentwärmespeicher
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
WO1996037256A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
US5599822A (en) * 1995-06-06 1997-02-04 Eli Lilly And Company Methods for minimizing bone loss
ATE219374T1 (de) 1996-02-01 2002-07-15 Chugai Pharmaceutical Co Ltd Medikamente für die behandlung oder vorbeugung von thrombocytopenie
US5935607A (en) * 1996-02-15 1999-08-10 Hadasit Medical Research Services And Development Company Ltd. Treatment of osteoporosis
DE69719761T2 (de) * 1996-06-18 2003-12-18 Alza Corp Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
US5916524A (en) * 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
US5741554A (en) * 1996-07-26 1998-04-21 Bio Dot, Inc. Method of dispensing a liquid reagent
US5738728A (en) * 1996-07-26 1998-04-14 Bio Dot, Inc. Precision metered aerosol dispensing apparatus
US5743960A (en) * 1996-07-26 1998-04-28 Bio-Dot, Inc. Precision metered solenoid valve dispenser
ATE304020T1 (de) * 1996-07-31 2005-09-15 Gen Hospital Corp Parathyroidhormon-verwandthe peptidanaloge
JP4054381B2 (ja) 1996-09-17 2008-02-27 デカ・プロダクツ・リミテッド・パートナーシップ 移送による薬伝達システム
US6239144B1 (en) * 1997-04-03 2001-05-29 Eli Lilly And Company Methods of treating bone loss
IL120943A (en) * 1997-05-29 2004-03-28 Univ Ben Gurion A system for administering drugs through the skin
JP2001519384A (ja) * 1997-10-14 2001-10-23 イーライ・リリー・アンド・カンパニー 骨の構築と維持のための方法
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
CA2313700C (en) * 1997-12-11 2009-11-24 Alza Corporation Device for enhancing transdermal agent flux
CN1161164C (zh) * 1997-12-11 2004-08-11 阿尔扎有限公司 用于通过体表导入或提取质剂的装置
WO1999029365A1 (en) 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
EP0922467A3 (en) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretic drug delivery
EA200000672A1 (ru) 1997-12-18 2000-12-25 Эли Лилли Энд Компани Кристалический терипаратид
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
US20040033950A1 (en) * 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
EP1109594B1 (en) * 1998-08-31 2004-10-27 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
CA2245903A1 (en) 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
WO2000019823A1 (en) 1998-10-07 2000-04-13 The Board Of Trustees Of The University Of Arkansas Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
JP2003533167A (ja) 1998-11-25 2003-11-11 ザ ゼネラル ホスピタル コーポレーション アミノ末端改変副甲状腺ホルモン（ｐｔｈ）アナログ
US6884427B1 (en) 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
DE60024118T2 (de) 1999-09-20 2006-07-27 Eli Lilly And Co., Indianapolis Verwendung einer parathyroidhormone zur reduktion des krebsrisikos
CA2387693A1 (en) 1999-09-20 2001-03-29 Eli Lilly And Company Method for monitoring treatment with a parathyroid hormone
US6623457B1 (en) 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US8465468B1 (en) * 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020095134A1 (en) 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US20050008683A1 (en) 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US6589202B1 (en) 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
US6440096B1 (en) 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
DE60111771T2 (de) * 2000-10-13 2006-05-04 Alza Corp., Mountain View Mikroklingeanordungsaufprallapplikator
RU2278623C2 (ru) * 2000-10-13 2006-06-27 Алза Корпорейшн Держатель микровыступающего элемента для силового аппликатора
MXPA03003299A (es) 2000-10-13 2004-12-13 Johnson & Johnson Aparato y metodo para perforacion de la piel con microsalientes.
NZ525551A (en) * 2000-10-26 2005-09-30 Alza Corp Transdermal drug delivery devices having coated microprotrusions
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002074173A1 (en) * 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
CN101129327A (zh) * 2001-04-20 2008-02-27 阿尔扎公司 具有包含有益药剂的涂层的微小突出物阵列
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
US20030135201A1 (en) 2001-09-28 2003-07-17 Gonnelli Robert R. Microneedle with membrane
US6689100B2 (en) 2001-10-05 2004-02-10 Becton, Dickinson And Company Microdevice and method of delivering or withdrawing a substance through the skin of an animal
AU2002363412A1 (en) 2001-11-05 2003-05-19 Eli Lilly And Company Method for improving stability of a bone-connecting implant
WO2003048031A2 (en) * 2001-11-30 2003-06-12 Alza Corporation Methods and apparatuses for forming microprojection arrays
WO2003053258A1 (en) * 2001-12-20 2003-07-03 Alza Corporation Skin-piercing microprojections having piercing depth control
US7015262B2 (en) 2002-05-01 2006-03-21 Lifescan, Inc. Hydrophilic coatings for medical implements
AU2003239869A1 (en) 2002-05-23 2003-12-12 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
CN100464800C (zh) * 2002-06-28 2009-03-04 阿尔扎公司 具有被涂覆的微突物的经皮药物传输装置
US20040115167A1 (en) * 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
AU2004255218A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
DK1638468T3 (da) * 2003-06-30 2007-12-17 Alza Corp Fremgangsmåde til coating af hudpiercingmikrofremspring
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
ATE509207T1 (de) * 2003-07-10 2011-05-15 Skf Ab Lagereinheit mit lot- oder hartlotverbindung
BRPI0412664A (pt) 2003-07-15 2006-09-26 Ca Nat Research Council método para tratar uma condição caracterizada por hiperproliferação de células da pele em um indivìduo em risco ou portador dessa condição e utilização de uma quantidade terapeuticamente efetiva de um análogo cìclico de hormÈnio de paratireóide humano (hpth)
EP1654030A1 (en) * 2003-08-04 2006-05-10 Alza Corporation Method and device for enhancing transdermal agent flux
KR20060097751A (ko) * 2003-10-24 2006-09-15 알자 코포레이션 경피 약물 전달을 증대시키기 위한 장치 및 방법
CN1897883A (zh) * 2003-10-28 2007-01-17 阿尔扎公司 通过涂覆的微喷射体释放治疗用肽和蛋白的聚合物缀合物
EP1680154B1 (en) * 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
JP5388415B2 (ja) * 2003-11-13 2014-01-15 アルザ・コーポレーシヨン 経皮送達のための組成物及び装置
EP1557176A1 (en) 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
EP1744683B1 (en) * 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
AU2005260834A1 (en) 2004-07-14 2006-01-19 Chugai Seiyaku Kabushiki Kaisha PTH-containing preparation for transmucosal administration
WO2006052991A2 (en) 2004-11-11 2006-05-18 The General Hosptial Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
JP5277456B2 (ja) 2005-01-31 2013-08-28 アルザ コーポレイション 低い変動性を有するコーティングマイクロプロジェクション、及びその生成法

Also Published As

Publication number Publication date
US8361022B2 (en) 2013-01-29
JP2007536988A (ja) 2007-12-20
US20100160895A1 (en) 2010-06-24
EP1744683A2 (en) 2007-01-24
US9295714B2 (en) 2016-03-29
IL179197A0 (en) 2007-03-08
US20100152649A1 (en) 2010-06-17
US8633159B2 (en) 2014-01-21
US7556821B2 (en) 2009-07-07
JP5309203B2 (ja) 2013-10-09
JP5007427B2 (ja) 2012-08-22
EP1744683B1 (en) 2016-03-16
US20100119568A1 (en) 2010-05-13
EP1744683A4 (en) 2010-09-29
US20050256045A1 (en) 2005-11-17
BRPI0509788A (pt) 2007-10-23
CA2566032A1 (en) 2005-12-01
ES2568259T3 (es) 2016-04-28
JP2012097087A (ja) 2012-05-24
NO20065720L (no) 2007-02-13
AR048887A1 (es) 2006-06-07
WO2005112984A2 (en) 2005-12-01
AU2005244734A1 (en) 2005-12-01
WO2005112984A3 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
MXPA06013168A (es) Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
EP2001453A4 (en) APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE AGENTS FOR TREATING OR PREVENTING OSTEOPENIA
TW200602099A (en) Apparatus and method for transdermal delivery of fentanyl-based agents
TW200600132A (en) Frequency assisted transdermal agent delivery method and system
TW200616660A (en) Apparatus and method for transdermal delivery of natriuretic peptides
WO2005099751A3 (en) Apparatus and method for transdermal delivery of influenza vaccine
TW200618830A (en) Micorprojection apparatus and system with low infection potential
TW200600107A (en) Apparatus and method for transdermal delivery of multiple vaccines
WO2005051455A3 (en) Ultrasound assisted transdermal vaccine delivery method and system
TW200502017A (en) Active agent delivery device having composite members
TW200517156A (en) Pretreatment method and system for enhancing transdermal drug delivery
TW200621316A (en) Apparatus and method for transdermal delivery of vascular endothelial growth factors
MXPA03003815A (es) Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
WO2004105729A3 (en) Transdermal vaccine delivery device having coated microprotrusions
WO2004030743A3 (en) Drug delivery device having coated microprojections incorporating vasoconstrictors
TW200613029A (en) System and method for drug delivery and microfluidic applications using microneedles
AR047229A1 (es) Administracion de conjugados polimericos de peptidos y proteinas terapeuticos por medio de microproyecciones revestidas
WO2007011788A3 (en) Skin penetrating device and method of use
JP2006525316A5 (es)
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
EA200601129A1 (ru) Способ лечения нежелательного эффекта при чрескожной доставке лекарства (варианты)
TW200738252A (en) Apparatus and method for transdermal delivery of Epoetin-based agents
CA2569285A1 (en) Methods of device-assisted drug delivery
TW200602019A (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006113796A3 (en) Microbial cellulose materials for use in transdermal drug delivery system